benefits of microdosing glp 1 GLP-1 GLP-1 (glucagon-like peptide-1) receptor agonists, such as tirzepatide (Zepbound) or semaglutide (Ozempic, Wegovy), are typically prescribed for diabetes and obesity management at standard therapeutic doses. Microdosing Microdosing GLP-1s: Does It Work?

(2012) 2012:CD007280

For a country with over 10 crore adults living with diabetes and an estimated 25 crore with obesity, the price reduction represents a significant accessibility shift, creating both opportunity and risk

The most reliable and easy rule is: Eat your goal weight in grams of protein per day

Gastrointestinal AE with cagrisema were more than with semagutide or cagrilintide monotherapy, however the SAE and AE leading to medication discontinuation were minimal and similar between the groups [87, 90] A programme of phase 3 clinical trials (REDEFINE) assessing the safety and efficacy of cagrisema in people with obesity (NCT05567796, NCT05394519, NCT05813925) is currently ongoing

This distinction matters, especially as some patients refer to IV treatments as skin lightening shots, which can be misleading